Cardiac-specific expression of the N1325S mutation of SCN5A in transgenic mouse hearts (TG-NS) resulted in long QT syndrome (LQTS), ventricular arrhythmias (VT), and heart failure. In this study we carried out oligonucleotide mircoarray analysis to identify genes that are differentially expressed in the TG-NS mouse hearts. We identified 33 genes in five different functional groups that showed differential expression. None of the 33 genes are ion channel genes. STAT1, which encodes a transcription factor involved in apoptosis and interferon response, showed the most significant difference of expression between TG-NS and control mice (a nearly 10-fold increase in expression, P = 4 × 10 −6 ). The results were further confirmed by quantitative real-time PCR and Western blot analyses. Accordingly, many interferon response genes also showed differential expression in TG-NS hearts. This study represents the first microarray analysis for LQTS and implicates STAT1 in the pathogenesis and progression of LQTS and heart failure.
KeywordsCardiac sodium channel gene SCN5A mutation N1325S; Long QT syndrome (LQTS) and ventricular tachycardia; Microarray analysis; Dilated cardiomyopathy and heart failure; STAT1The long QT syndrome (LQTS) is characterized by prolongation of the QT interval and T wave abnormalities on electrocardiograms (ECG) [1,2]. LQTS is associated with symptoms including syncope, seizures and sudden death caused by a specific ventricular arrhythmia, torsade de pointes [1,2]. One of the major genes identified for LQTS is the SCN5A gene on chromosome 3p21-23 (LQT3), which accounts for 10-20% LQTS cases [2,3]. SCN5A © 2007 Elsevier Inc. All rights reserved. * Corresponding author. Address: Center for Cardiovascular Genetics/NE4-202, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, USA. Fax: +1 216 636 1231 wangq2@ccf.org. . Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. The N1325S mutation in SCN5A is a substitution of an asparagine residue by a serine at position 1325 in the intercellular region of domain III S4-S5 of Na v 1.5, and is one of the earliest mutations identified in LQT3 families [3]. It disrupts the Na + channel inactivation and generates the late persistent I Na inward current. Overexpression of the N1325S mutation in Xenopus oocytes and HEK293 cells induced dispersed reopening in the late inactivation phase, which produced a late persistent inward sodium current [10][11][12]. We have expressed the SCN5A N1325S mutation in the mouse heart (TG-NS mice) [13]. The TG-NS transgenic mice showed prolongation of the QT in...